Neuroanesthesiology review - 2004

Journal of Neurosurgical Anesthesiology

Volumn 17, Issue 1, 2005, Pages 2-8

  Pasternak, Jeffrey J ^a   Lanier, William L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; CARBON DIOXIDE; CLONIDINE; DESFLURANE; DEXAMETHASONE; DEXMEDETOMIDINE; ENOXAPARIN; GLUCOSE; ISOFLURANE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; NARCOTIC AGENT; PROPOFOL; REMIFENTANIL; ROPIVACAINE; SEVOFLURANE; SUFENTANIL;

AIRWAY; ANESTHESIA; BISPECTRAL INDEX; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONCENTRATION RESPONSE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; GLUCOSE BLOOD LEVEL; HEAD INJURY; HOSPITAL MANAGEMENT; HUMAN; HYPOTHERMIA; INTENSIVE CARE; LUNG CLEARANCE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; PATIENT MONITORING; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SEDATION; SUBARACHNOID HEMORRHAGE; T WAVE; VASOCONSTRICTION; VASOSPASM;

ANESTHESIOLOGY; ANESTHETICS; HUMANS; HYPOTHERMIA, INDUCED; INTUBATION, INTRATRACHEAL; MONITORING, INTRAOPERATIVE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; NEUROSURGERY;

EID: 11244275454     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Tongier WK, Joshi GP, Landers DF, et al. Use of the laryngeal mask airway during awake craniotomy for tumor resection. J Clin Anesth. 2000; 12:592-594.
2. Fukaya C, Katayama Y, Yoshino A, et al. Intrapoerative wake-up procedure with propofol and laryngeal mask for optimal excision of brain tumour in eloquest areas. J Clin Neurosci. 2001;8:253-255.
3. Audu PB, Loomba N. Use of cuffed oropharyngeal airway (COPA) for awake intracranial surgery. J Neurosurg Anesthesiol. 2004;16:144-146.
4. Hagberg CA, Gollas A, Berry JM. The laryngeal mask airway for awake craniotomy in the pediatric patient: report of three cases, J Clin Anesth. 2004;16:43-47.
5. Sagi HC, Beutler W, Carroll E, et al. Airway complications associated with surgery on the anterior cervical spine. Spine. 2002;27:949-953.
6. Epstein NE, Hollingsworth R, Nardi D, et al. Can airway complications following multilevel anterior cervical surgery be avoided? J Neurosurg Spine. 2001;94:185-188.
7. Terao Y, Matsumoto S, Yamashita K, et al. Increased incidence of emergency airway management after combined anterior-posterior cervical spine surgery. J Neurosurg Anesthesiol. 2004;16:282-286.
8. Kingdom TT, Nockels RP, Kaplan MJ. Transoral-transpharyngeal approach to the craniocervical junction. Otolaryngol Head Neck Surg. 1995;113:393-400.
9. Pandey CK, Azim A, Matreja P, et al. Effect of preoperative dexamethasone on edema of oral and extra-oral structures following trans-oral decompression and posterior fusion. J Neurosurg Anesthesiol. 2004;16:267-270.
10. Schmitt H, Buchfelder M, Radespiel-Troger M, et al. Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology. 2000;93:110-114.
11. Law-Koune JD, Liu N, Szekely B, et al. Using the intubating laryngeal mask airway for ventilation and endotracheal intubation in anesthetized and unparalyzed acromegalic patients. J Neurosurg Anesthesiol. 2004;16: 11-13.
12. Holmstrom A, Akeson J. Desflurane increases intracranial pressure more and sevoflurane less than isoflurane in pigs subjected to intracranial hypertension. J Neurosurg Anesthesiol. 2004;16:136-143.
13. Holmstrom A, Rosen I, Akeson J. Desflurane results in higher cerebral blood flow than sevoflurane or isoflurane at hypocapnia in pigs. Acta Anaesthesiol Scand. 2004;48:400-404.
14. Kaye A, Kucera IJ, Heavner J, et al. The comparative effects of desflurane and isoflurane on lumbar cerebrospinal fluid pressure in patients undergoing craniotomy for supratentorial tumors. Anesth Analg. 2004;98:1127-1132.
15. Khan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth. 1999;83:372-380.
16. Arain SR, Ruehlow RM, Uhrich TD, et al. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg. 2004;98:153-158.
17. Prielipp RC, Wall MH, Tobin JR, et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cecebal blood flow. Anesth Analg. 2002;95:1052-1059.
18. Bekker AY, Kaufman B, Samir H, et al. The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg. 2001;92:1251-1253.
19. Bustillo MA, Lazar RM, Finck AD, et al. Dexmedetomidine may impair cognitive testing during endovascular embolization of cerebral arteriovenous malformations: a retrospective case report series. J Neurosurg Anesthesiol. 2002;14:209-212.
20. Lotto M BS, Ebrahim Z, Schubert A. Successful cognitive testing in patients undergoing awake craniotomy with dexmedetomidine and propofol sedation. J Neurosurg Anesthesiol. 2003;15:376.
21. Mack PF, Perrine K, Kobylarz E, et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol. 2004; 16:20-25.
22. Bekker AY, Basile J, Gold M, et al. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol. 2004;16:126-135.
23. Zornow MH, Fleischer JE, Scheller MS, et al. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane- anesthetized dog. Anesth Analg. 1990;70:624-630.
24. Lee HW, Caldwell JE, Dodson B, et al. The effect of clonidine on cerebral blood flow velocity, carbon dioxide cerebral vasoreactivity, and response to increased arterial pressure in human volunteers. Anesthesiology. 1997; 87:553-558.
25. Maekawa T, Cho S, Fukusaki M, et al. Effects of clonidine on human middle cerebral artery flow velocity and cerebrovascular CO2 response during sevoflurane anesthesia. J Neurosurg Anesthesiol. 1999;11;173-177.
26. Mirzai H, Tekin I, Tarhan S, et al. Effect of propofol and clonidine on cerebral blood flow velocity and carbon dioxide reactivity in the middle cerebral artery. J Neurosurg Anesthesiol. 2004;16:1-5.
27. Costello TG, Cormack JR, Hoy C, et al. Plasma ropivacaine levels following scalp block for awake craniotomy. J Neurosurg Anesthesiol. 2004;16:147-150.
28. Scott DB, Lee A, Pagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg. 1989;69:563-569.
29. Kopacz DJ, Emanuelsson BM, Thompson GE, et al. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology. 1994;81:1139-1148.
30. Pasternak JJ, McGregor DG, Lanier WL. Effect of single-dose dexamethasone on blood glucose concentration in patients undergoing craniotomy. J Neurosurg Anesthesiol. 2004;16:122-125.
31. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc. 1996;71:801-812.
32. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992-1000.
33. Wiedemayer H, Sandalcioglu IE, Armbruster W, et al. False negative findings in intraoperative SEP monitoring: analysis of 658 consecutive neurosurgical cases and review of published reports. J Neurol Neurosurg Psychiatry. 2004;75:280-286.
34. Jones SJ, Harrison R, Koh KF, et al. Motor evoked potential monitoring during spinal surgery: responses of distal limb muscles to transcranial cortical stimulation with pulse trains. Electroencephalogr Clin Neurophysiol. 1996;100:375-383.
35. Pechstein U, Cedzich C, Nadstawek J, et al. Transcranial high-frequency repetitive electrical stimulation for recording myogenic motor evoked potentials with the patient under general anesthesia. Neurosurgery. 1996;39:335-343; discussion 343-344.
36. Taniguchi M, Cedzich C, Schramm J. Modification of cortical stimulation for motor evoked potentials under general anesthesia: technical description. Neurosurgery. 1993;32:219-226.
37. Zhou HH, Mehta M, Leis AA. Spinal cord motoneuron excitability during isoflurane and nitrous oxide anesthesia. Anesthesiology. 1997;86:302-307.
38. Suzuki K, Kodama N, Sasaki T, et al. Intraoperative monitoring of blood flow insufficiency in the anterior choroidal artery during aneurysm surgery. J Neurosurg. 2003;98:507-514.
39. Quinones-Hinojosa A, Alam M, Lyon R, et al. Transcranial motor evoked potentials during basilar artery aneurysm surgery: technique application for 30 consecutive patients. Neurosurgery. 2004;54:916-924; discussion 924.
40. Lotto ML, Banoub M, Schubert A. Effects of anesthetic agents and physiologic changes on intraoperative motor evoked potentials. J Neurosurg Anesthesiol. 2004;16:32-42.
41. Myles PS, Leslie K, McNeil J, et al. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004;363:1757-1763.
42. De Deyne C, Struys M, Decruyenaere J, et al. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med. 1998;24:1294-1298.
43. Simmons LE, Riker RR, Prato BS, et al. Assessing sedation during intensive care unit mechanical ventilation with the Bispectral Index and the Sedation-Agitation Scale. Crit Care Med. 1999;27:1499-1504.
44. Gilbert TT, Wagner MR, Halukurike V, et al. Use of bispectral electroencephalogram monitoring to assess neurologic status in unsedated, critically ill patients. Crit Care Med. 2001;29:1996-2000.
45. Fabregas N, Gambus PL, Valero R, et al. Can bispectral index monitoring predict recovery of consciousness in patients with severe brain injury? Anesthesiology. 2004;101:43-51.
46. Mackenzie CF. Threats and opportunities in pre-hospital management of traumatic brain injury. J Neurosurg Anesthesiol. 2004;16:70-74.
47. Baumgartner WA. Neurologic injury after cardiopulmonary bypass surgery. J Neurosurg Anesthesiol. 2004;16:102-104.
48. Gilbert TB. Acute visual loss following cardiopulmonary bypass: model case presentation and discussion. J Neurosurg Anesthesiol. 2004;16:75-76.
49. Lauer KK. Visual loss after spine surgery. J Neurosurg Anesthesiol. 2004; 16:77-79.
50. Johnson ME. Neurotoxicity of lidocaine: implications for spinal anesthesia and neuroprotection. J Neurosurg Anesthesiol. 2004;16:80-83.
51. Liguori GA. Complications of regional anesthesia: nerve injury and peripheral neural blockade. J Neurosurg Anesthesiol. 2004;16:84-86.
52. Warner DS. Pharmacologic protection from ischemic neuronal injury. J Neurosurg Anesthesiol. 2004;16:95-97.
53. Fiskum G. Mechanisms of neuronal death and neuroprotection. J Neurosurg Anesthesiol. 2004;16:108-110.
54. Simard JM, Chen M. Regulation by sulfanylurea receptor type 1 of a nonselective cation channel involved in cytotoxic edema of reactive astrocytes. J Neurosurg Anesthesiol. 2004;16:98-99.
55. Hemmings HC Jr. Neuroprotection by Na+ channel blockade. J Neurosurg Anesthesiol. 2004;16:100-101.
56. Recio-Pinto E, Nikonorov IM, Blanck TJ. G-protein activation decreases the isoflurane inhibition of N-type Ca2+ currents: an increase in the isoflurane blocking potency of N-type Ca2+ currents may contribute to the known neuroprotection action of isoflurane during ischemia. J Neurosurg Anesthesiol. 2004;16:105-107.
57. Doppenberg E, Choi SC, Bullock R. Clinical trials in traumatic brain injury: lessons for the future. J Neurosurg Anesthesiol. 2004;16:87-94.
58. Hunt K, Bajekal R, Calder I, et al. Changes in intraocular pressure in anesthetized prone patients. J Neurosurg Anesthesiol. 2004;16:287-290.
59. Kawaguchi M, Kimbro JR, Drummond JC, et al. Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology. 2000;92:1335-1342.
60. Elsersy H, Sheng H, Lynch JR, et al. Effects of isoflurane versus fentanylnitrous oxide anesthesia on long-term outcome from severe forebrain ischemia in the rat. Anesthesiology. 2004;100:1160-1166.
61. Inoue S, Drummond JC, Davis DP, et al. Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjected to focal cerebral ischemia. Anesthesiology. 2004;101:75-81.
62. Izumi Y, Roussel S, Pinard E, et al. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab. 1991;11:1025-1030.
63. Marinov MB, Harbaugh KS, Hoopes PJ, et al. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg. 1996;85:117-124.
64. Muir KW, Lees KR, Ford I, et al. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet. 2004;363:439-445.
65. Lampl Y, Gilad R, Geva D, et al. Intravenous administration of magnesium sulfate in acute stroke: a randomized double-blind study. Clin Neuropharmacol. 2001;24:11-15.
66. Crowther CA, Hiller JE, Doyle LW, et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290:2669-2676.
67. Wass CT, Lanier WL. Hypothermia-associated protection from ischemic brain injury: implications for patient management. Int Anesthesiol Clin. 1996;34:95-111.
68. Cottrell JE, Harrung J. Cool it on cooling: at least during aneurysm surgery. J Neurosurg Anesthesiol. 2004;16:113-114.
69. Todd M, Hindman R, Clark W, et al. Intraoperative Hypothermia for Intracranial Aneurysm Surgery (IHAST): Initial Results. Presented at the 29th International Stroke Conference, San Diego, February 7, 2004.
70. Kimme P, Fridrikssen S, Engdahl O, et al. Moderate hypothermia for 359 operations to clip cerebral aneurysms. Br J Anaesth. 2004;93:343-347.
71. Steinberg GK, Ogilvy CS, Shuer LM, et al. Comparison of endovascular and surface cooling during unruptured cerebral aneurysm repair. Neurosurgery. 2004;55:307-314; discussion 314-315.
72. Shiraki K, Sagawa S, Tajima F, et al. Independence of brain and tympanic temperatures in an unanesthetized human. J Appl Physiol. 1988;65:482-486.
73. Christensen H, Boysen G. Acceptable agreement between tympanic and rectal temperature in acute stroke patients. Int J Clin Pract. 2002;56:82-84.
74. Newsham KR, Saunders JE, Nordin ES. Comparison of rectal and tympanic thermometry during exercise. South Med J. 2002;95:804-810.
75. Zweifler RM, Voorhees ME, Mahmood MA, et al. Rectal temperature reflects tympanic temperature during mild induced hypothermia in nonintubated subjects. J Neurosurg Anesthesiol. 2004;16:232-235.
76. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007-1017.
77. Mayer SA, LiMandri G, Sherman D, et al. Electrocardiographic markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg. 1995;83:889-896.
78. Zaroff JG, Rordorf GA, Newell JB, et al. Cardiac outcome in patients with subarachnoid hemorrhage and electrocardiographic abnormalities. Neurosurgery. 1999;44:34-39; discussion 39-40.
79. Collier BR, Miller SL, Kramer GS, et al. Traumatic subarachnoid hemorrhage and QTc prolongation. J Neurosurg Anesthesiol. 2004;16:196-200.
80. Sviri GE, Feinsod M, Soustiel JF. Brain natriuretic peptide and cerebral vasospasm in subarachnoid hemorrhage: clinical and TCD correlations. Stroke. 2000;31:118-122.
81. McGirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004;54:1369-1373; discussion 1373-1374.
82. Khurana VG, Wijdicks EF, Heublein DM, et al. A pilot study of dendroaspis natriuretic peptide in aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55:69-75; discussion 75-76.
83. Wurm G, Tomancok B, Nussbaumer K, et al. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg. 2004;106:97-103.
84. Bronchard R, Albaladejo P, Brezac G, et al. Early onset pneumonia: risk factors and consequences in head trauma patients. Anesthesiology. 2004; 100:234-239.
85. Metz C, Kasprzak P, Moritz S, et al. Reliability of cerebrovenous lactate measurements in detecting brain ischemia in man. J Neurosurg Anesthesiol. 1999;11:314.
86. Sperry RJ, Bailey PL, Reichman MV, et al. Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Anesthesiology. 1992;77:416-420.
87. Engelhard K, Reeker W, Kochs E, et al. Effect of remifentanil on intracranial pressure and cerebral blood flow velocity in patients with head trauma. Acta Anaesthesiol Scand. 2004;48:396-399.
88. Zetterling M, Ronne-Engstrom E. High intraoperative blood loss may be a risk factor for postoperative hematoma. J Neurosurg Anesthesiol. 2004; 16:151-155.